LXRX logo

LXRX
Lexicon Pharmaceuticals Inc

13,630
Mkt Cap
$959.46M
Volume
1.63M
52W High
$2.53
52W Low
$0.615
PE Ratio
-30.21
LXRX Fundamentals
Price
$2.16
Prev Close
$2.23
Open
$2.23
50D MA
$1.80
Beta
1.65
Avg. Volume
1.9M
EPS (Annual)
-$0.1387
P/B
4.51
Rev/Employee
$614,851.85
$383.52
Loading...
Loading...
News
all
press releases
Lexicon Pharmaceuticals (LXRX) Reports Break-Even Earnings for Q1
Lexicon (LXRX) delivered earnings and revenue surprises of +100.00% and +141.91%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
More News
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Shares Cross Above 200-Day Moving Average - Here's What Happened
Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Price Passes Above 200-Day Moving Average - Here's What Happened...
News Placeholder
Lexicon Pharmaceuticals (LXRX) to Release Earnings on Thursday
Lexicon Pharmaceuticals (NASDAQ:LXRX) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-lexicon-pharmaceuticals-inc-stock...
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Reaches New 1-Year High - Here's Why
Lexicon Pharmaceuticals (NASDAQ:LXRX) Reaches New 52-Week High - What's Next...
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Reaches New 52-Week High - Should You Buy?
Lexicon Pharmaceuticals (NASDAQ:LXRX) Reaches New 52-Week High - Still a Buy...
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Trading 6.3% Higher - Still a Buy?
Lexicon Pharmaceuticals (NASDAQ:LXRX) Trading Up 6.3% - Here's What Happened...
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Passes Above Two Hundred Day Moving Average - What's Next?
Lexicon Pharmaceuticals (NASDAQ:LXRX) Shares Pass Above 200 Day Moving Average - Here's What Happened...
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Trading 8.7% Higher - Time to Buy?
Lexicon Pharmaceuticals (NASDAQ:LXRX) Trading 8.7% Higher - Should You Buy...
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Passes Above Two Hundred Day Moving Average - Here's Why
Lexicon Pharmaceuticals (NASDAQ:LXRX) Share Price Passes Above 200 Day Moving Average - Should You Sell...
News Placeholder
LXRX Stock Up as NVO Initiates Phase I Study of Partnered Obesity Drug
Lexicon Pharmaceuticals stock jumps as NVO launches phase I study of oral obesity candidate LX9851, advancing a promising partnered therapy.
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available